Empowering healthcare with AI: LungDiag NLP system transforms respiratory disease diagnosis

FHS
July 14, 2023
10:06 am

An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.

Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq | Psychedelic Invest

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on September 12, 2024, the Company received a staff determination letter (the “Determination

September 16, 2024

PF-08046054 by Pfizer for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

February 21, 2024

New AGA Guideline; Imaging for HCC Surveillance; ‘Breakthrough’ Hepatitis D Drug

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at high risk for hepatitis B reactivation. (Gastroenterology) Researchers identified

January 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.